Literature DB >> 2202505

Aggregation of Actinomyces strains by extracellular vesicles produced by Bacteroides gingivalis.

G Bourgeau1, D Mayrand.   

Abstract

The aggregation of Actinomyces viscosus and Actinomyces naeslundii with extracellular vesicles of Bacteroides gingivalis was studied. Factors influencing the aggregation phenomenon were examined. L-Arginine was found to effectively inhibit aggregation as was an antibody preparation directed against a B. gingivalis surface hemagglutinin. Aggregation occurred over a wide pH range and did not seem to be affected by high salt concentrations or the presence of carbohydrates. Treatment of the vesicle preparation with proteases, sodium dodecyl sulphate, and high temperatures diminished or eliminated aggregation, while similar treatment of the Actinomyces had no effect on aggregation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2202505     DOI: 10.1139/m90-063

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  4 in total

1.  Evidence that Porphyromonas (Bacteroides) gingivalis fimbriae function in adhesion to Actinomyces viscosus.

Authors:  P A Goulbourne; R P Ellen
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

2.  Adhesion of Actinomyces viscosus to Porphyromonas (Bacteroides) gingivalis-coated hexadecane droplets.

Authors:  M Rosenberg; I A Buivids; R P Ellen
Journal:  J Bacteriol       Date:  1991-04       Impact factor: 3.490

3.  Isolation and characterization of a cloned Porphyromonas gingivalis hemagglutinin from an avirulent strain of Salmonella typhimurium.

Authors:  D M Dusek; A Progulske-Fox; J Whitlock; T A Brown
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

4.  Characterization of a Tn4351-generated hemin uptake mutant of Porphyromonas gingivalis: evidence for the coordinate regulation of virulence factors by hemin.

Authors:  C A Genco; W Simpson; R Y Forng; M Egal; B M Odusanya
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.